Blood and Marrow Transplant Program
The joint UC San Diego Health / Sharp HealthCare program is the largest blood and marrow transplant (BMT) program in San Diego and one of the largest in California. A national leader in physician expertise and state-of-the-art treatment, our program is a proud member of the Blood and Marrow Transplant Clinical Trials Network of the National Institutes of Health.
Studies have shown that the best patient outcomes occur in centers that perform a high volume of specific medical procedures, such as BMT.
Our interdisciplinary team of physicians, advanced practitioners, nurses, social workers and support staff works together to manage every aspect of a patient's experience, including nutrition, side effects, education and support resources for caregivers and their families, and follow-up care.
- Lymphoma and Hodgkin's disease
- Acute and chronic leukemia
- Multiple myeloma
- Myelodysplastic syndrome
- Aplastic anemia
- Testicular cancer
Volume and Outcomes
Since 1989, we have performed more than 2,000 transplants. Data from our transplants are reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) and the National Marrow Donor Program (NMDP) for entry into the Stem Cell Therapeutics Outcomes Database (SCTOD).
We treat patients with currently available standard-of-care therapies, as well as innovative chemotherapy agents, radiation therapy techniques and novel stem cell transplantation methods, including:
- Reduced intensity treatment, which administers a lower dose of chemotherapy and radiation
- Autologous transplants
- Allogeneic transplants – related and unrelated
- Cord blood and haploindentical stem cell transplant
- Induction and salvage therapies for newly diagnosed and relapsed/refractory hematologic malignancies
For more information, see About BMT or Transplant Process.
Accreditation and Credentials
The UC San Diego / Sharp Blood and Marrow Transplant Program is one of 16 charter members of the prestigious Blood and Marrow Transplant Clinical Trials Network (BMT CTN) of the National Institutes of Health (NIH). With about 20 transplant center members, this is the premier BMT clinical trials group in the world. The majority of BMT procedures performed in the U.S. are by centers who are members of BMT CTN.
Our program is also accredited by or a member of the following organizations:
In addition, we are one of only 45 National Cancer Institute-designated comprehensive cancer centers in the U.S.
See more information about blood and marrow transplants through our program: